Home›Search›Endocrine Oncology

Endocrine Oncology

Bioscientifica · United Kingdom

eISSN2634-4793

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.397

H-Indexi

Aims & Scope✦ Inferred from recent articles

This journal focuses on neuroendocrine neoplasms (NENs) and related conditions, including adrenocortical carcinoma, pituitary tumors, and thyroid cancer. It covers the molecular genetics, diagnosis, treatment, and outcomes of these diseases. Research includes hereditary syndromes like multiple endocrine neoplasia (MEN), specific tumor types such as paragangliomas and pancreatic neuroendocrine tumors, and the impact of treatments like mitotane and peptide receptor radionuclide therapy (PRRT). The scope also extends to patient-reported outcomes, treatment-related side effects, and the role of genetic factors in disease development and management.

AI-summarised from recent articles · verify on publisher page →

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published—

StatusActive

Total Publications—

Publisher OrgBioscientifica

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY, CC BY-NC, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/11 · 82%

✅

Do you know the journal / publisher?

Bioscientifica

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2634-4793

✅

Indexed in a trusted database?

Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Endocrinology, Diabetes and MetabolismQ3

OncologyQ3

Cancer ResearchQ4

EndocrinologyQ4

Subject Classification

Research Topics (OpenAlex)

Neuroendocrine Tumor Research AdvancesPituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic TumorsThyroid Cancer Diagnosis and TreatmentEstrogen and related hormone effectsLung Cancer Research StudiesNeuroblastoma Research and TreatmentsGrowth Hormone and Insulin-like Growth FactorsProstate Cancer Treatment and ResearchThyroid and Parathyroid Surgery

Frequently asked questions about Endocrine Oncology

Is Endocrine Oncology a predatory journal?

PubScope has no integrity flags on record for Endocrine Oncology: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Endocrine Oncology?

Endocrine Oncology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.397.

Is Endocrine Oncology indexed in Scopus and Web of Science?

Endocrine Oncology is indexed in Scopus, DOAJ.